CASE REPORT
Growth velocity increase in children with Turner syndrome treated with growth hormone following
a brief therapy interruption
1
Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Poznań, Poland
Submission date: 2023-04-14
Acceptance date: 2023-05-05
Publication date: 2023-09-15
Corresponding author
Katarzyna Anna Majewska
Katarzyna Anna Majewska, MD, PhD, Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Poznań, Poland
Katarzyna Anna Majewska, MD, PhD, Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Poznań, Poland
Pediatr Pol 2023;98(3):264-266
KEYWORDS
TOPICS
ABSTRACT
Growth failure is a substantial feature of Turner syndrome (TS) and typically progresses from infancy to adulthood. Proper growth hormone (GH) treatment in TS is essential to increase growth velocity and improve the final height. The aim of the study was to perform a preliminary assessment of the influence of short interruptions in GH therapy on the growth process in children with TS. Growth velocities were analyzed in 5 patients with TS, treated long term with GH, who experienced short breaks in drug administration, followed by the re-introduction of treatment. The average growth velocity after the treatment interruption increased 2-fold compared to the continuous therapy and 1.3/1.5-fold compared to the period of initial GH therapy. The results suggest that the catch-up growth typical for the beginning of the GH therapy is not a single phenomenon and may recur in TS children in the case of re-introduction treatment after a short interruption.
REFERENCES (16)
1.
Quigley CA, Fechner PY, Geffner ME, et al. Prevention of growth failure in turner syndrome: long-term results of early growth hormone treatment in the “Toddler Turner” cohort. Horm Res Paediatr 2021; 94: 18-35.
2.
Blunden C, Nasomyont N, Backeljauw P. Growth hormone therapy for Turner syndrome. Pediatr Endocrinol Rev 2018; 16: 80-90.
3.
Wasniewska M, De Luca F, Bergamaschi R, et al. Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect. Eur J Endocrinol 2004; 151: 567-572.
4.
Al Shaikh A, Daftardar H, Alghamdi AA, et al. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Acta Biomed 2020; 91: 29-40.
5.
Danowitz M, Grimberg A. Clinical indications for growth hormone therapy. Adv Pediatr 2022; 69: 203-217.
6.
Iughetti L, Madeo S, Predieri B. Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency. J Endocrinol Invest 2010; 33: 34-38.
7.
Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003; 88: 1119-1125.
8.
Davenport ML, Crowe BJ, Travers SH, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007; 92: 3406-3416.
9.
Van Dommelen P, Koledova E, Wit JM. Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency. PLoS One 2018; 13: e0206009.
10.
Gafni RI, Baron J. Catch-up growth: possible mechanisms. Pediatr Nephrol 2000; 14: 616-619.
11.
Dacou-Voutetakis C, Karavanaki-Karanassiou K, Petrou V, et al. The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment. Pediatrics 1998; 101: 663-668.
12.
Ramos AV, Silva IN, Goulart EM. Turner syndrome: searching for better outcomes. Clinics (Sao Paulo) 2008; 63: 173-178.
13.
Kędzia A, Majewska KA, Korcz M. Do the intervals in growth hormone therapy positively affect the growth velocity? Pediatr Endocrinol Diabetes Metab 2020; 26: 113-117.
14.
Phillip M, Lebenthal Y, Lebl J, et al. European Norditropin SGA Study Group. European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens. Horm Res 2009; 71: 52-59.
15.
Cavallo L, De Luca F, Bernasconi S, et al. The effect of different growth hormone administration frequencies on growth in growth hormone-deficient patients. Horm Res 1998; 49: 73-77.
16.
Wit JM, Ranke MB, Albertsson-Wikland K, et al. Personalized approach to growth hormone treatment: clinical use of growth prediction models. Horm Res Paediatr 2013; 79: 257-270.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
